Norcocaine is a potent modulator of haemodynamic responses, plasma catecholamines and cardiac hormone release in conscious rats

Toxicology

Volumn 128, Issue 2, 1998, Pages 101-111

  Mahlakaarto, Jaana ^a,b   Ruskoaho, Heikki ^a   Huttunen, Pirkko ^a   MacDonald, Ewen ^b   Pasanen, Markku ^a,c  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c NATIONAL AGENCY FOR MEDICINES   (Finland)

Author keywords

Cardiovascular toxicity; Cocaine; Norcocaine; Plasma ANP

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR DERIVATIVE; COCAINE; NORCOCAINE;

ADRENALIN BLOOD LEVEL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; HEART RATE; HEART RIGHT ATRIUM PRESSURE; HEMODYNAMICS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; CATECHOLAMINES; COCAINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; MALE; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0032479571     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(98)00053-5     Document Type: Article

References (46)

1. Billman, G.E., 1990. Mechanisms responsible for the cardiotoxic effects of cocaine. FASEB. J. 4, 2469-2475.
2. Boelsterli, U.A., Lanzotti, A., Göldlin, C., Oertle, M., 1992. Identification of cytochrome P-450IIB1 as a cocaine-bioactivating isoform in rat hepatic microsomes and in cultured rat hepatocytes. Drug Metab. Dispos. 20, 96-101.
3. Boyer, C.S., Ross, D., Petersen, D., 1988. Sex and strain differences in the hepatotoxic response to acute cocaine administration in the mouse. J. Biochem. Toxicol. 3, 295-307.
4. Brenner, B.M., Ballermann, B.J., Gunning, M.E., Zeidel, M.L., 1990. Diverse biological actions of atrial natriuretic peptide. Physiol. Rev. 70, 665-699.
5. Chiueh, C.C., Kopin, I.J., 1978. Centrally mediated release by cocaine of endogenous epinephrine and norepinephrine from the sympathoadrenal medullary system of unanesthetized rats. J. Pharmacol. Exp. Ther. 205, 148-154.
6. Cregler, L.L., Mark, H., 1985. Relation of acute myocardial infarction to cocaine abuse. Am. J. Cardiol. 56, 794.
7. Dietz, J.R., Nazian, S.J., Vesely, D.L., 1991. Release of ANF, proANF 1-98 and proANF 31-67 from isolated rat atria by atrial distension. Am. J. Physiol. 260, H1774-H1778.
8. Giros, B., Jaber, M., Jones, S.R., Wightman, R.M., Caron, M.G., 1996. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612.
9. Hale, S.L., Alker, K.J., Rezkalla, S., Figures, G., Kloner, R.A., 1989a. Adverse effects of cocaine in cardiovascular dynamics, myocardial blood flow and coronary artery diameter in an experimental model. Am. Heart J. 118, 927-933.
10. Hale, S.L., Lehmann, M.H., Kloner, R.A., 1989b. Electrocardiographic abnormalities after acute administration of cocaine in the rat. Am. J. Cardiol. 63, 1529-1530.
11. Hawks, R. L, Kopin, I.J., Colburn, R.W., Thoa, N.B., 1974. Norcocaine: A pharmacologically active metabolite of cocaine found in brain. Life Sci. 51, 2189-2195.
12. Itoh, H., Nakao, K., Sugawara, A., et al., 1988. Gamma-atrial natriuretic polypeptide (gamma ANP)-derived peptides in human plasma: cosecretion of N-terminal gamma ANP fragment and alpha ANP. J. Clin. Endocrinol. Metab. 67, 429-437.
13. Kalsner, S., 1992. Cocaine sensitization of coronary artery contractions: mechanism of drug-induced spasm. J. Pharmacol. Exp. Ther. 264, 1132-1140.
14. Kanel, G.C., Cassidy, W., Shuster, L., Reynolds, T., 1990. Cocaine-induced liver cell injury, comparison of morphological features in man and in experimental models. Hepatology 11, 646-651.
15. Katsube, N., Schwarz, D., Needleman, P., 1985. Release of atriopeptin in the rat by vasoconstrictors or water immersion correlates with changes in right atrial pressure. Biochem. Biophys. Res. Commun. 133, 937-944.
16. Katsube, N., Schwarz, D., Needleman, P., 1986. Atriopeptin turnover: quantitative relationship between in vivo changes in plasma levels and atrial content. J. Pharmacol. Exp. Ther. 239, 474-479.
17. King, K.A., Wong, A., Ledsome, J.R., 1991. The effect of isoproterenol on right and left atrial dynamics and plasma atrial natriuretic factor in anesthetized rabbits. Can. J. Physiol. Pharmacol. 69, 464-468.
18. Kiritsy-Roy, J.A., Halter, J.B., Gordon, S.M., Smith, M.J., Terry, L.C., 1990. Role of the central nervous system in hemodynamic and sympathoadrenal responses to cocaine in rats. J. Pharmacol. Exp. Ther. 225, 154-160.
19. Kleber, H.D., 1991. Tracking the cocaine epidemic. The drug abuse warning network. J. Am. Med. Assoc. 266, 2272-2273.
20. Kloner, R.A., Hale, S., Alker, K., Rezkalla, S., 1992. The effects of acute and chronic cocaine use on the heart. Circulation 85, 407-419.
21. Kloss, M.W., Rosen, G., Rauckman, E.J., 1984. Cocaine-mediated hepatotoxicity. A critical review. Biochem. Pharmacol. 33, 169-173.
22. Knuepfer, M.M., Branch, C.A., 1992. Cardiovascular responses to cocaine are initially mediated by the central nervous system in rats. J. Pharmacol. Exp. Ther. 263, 734-741.
23. Lang, R.E., Tholken, H., Ganten, D., Luft, F.C., Ruskoaho, H., Unger, T., 1985. Atrial natriuretic factor - a circulating hormone stimulated by volume loading. Nature 314, 264-266.
24. Morcos, N.C., Fairhurst, A., Henry, W.L., 1993. Direct myocardial effects of cocaine. Cardiovasc. Res. 27, 269-273.
25. Needleman, P., Blaine, E.H., Greenwald, J.E., et al., 1989. The biochemical pharmacology of atrial peptides. Annu. Rev. Pharmacol. Toxicol. 29, 23-54.
26. Pelkonen, M., Luodonpää, M., Vuolteenaho, O., Pasanen, M., Ruskoaho, H., 1996. Cocaine increases circulating levels of atrial natriuretic peptide and pro atrial natriuretic peptide N-terminal fragment levels in conscious rats. Eur. J. Pharmacol. 304, 55-62.
27. Pellinen, P., Honkakoski, P., Stenbäck, F., et al., 1994. Cocaine N-demethylation and the metabolism-related hepatotoxicity can be prevented by cytochrome P450 3A inhibitors. Eur. J. Pharmacol. Environ. Toxicol. Pharmacol. Sect. 270, 35-43.
28. Perreault, C.L., Hague, N.L., Morgan, K.G., Allen, P.D., Morgan, J.P., 1993. Negative inotropic and relaxant effects of cocaine on myopathic human ventricular myocardium and epicardial coronary arteries in vitro. Cardiovasc. Res. 27, 262-268.
29. Perrella, M.A., Margulies, K.B., Burnett, J.C. Jr., 1991. Pathophysiology of congestive heart failure: role of atrial natriuretic factor and therapeutic implications. Can. J. Physiol. Pharmacol. 69, 1576-1581.
30. Pitts, D.K., Udom, C.E., Marwah, J., 1987. Cardiovascular effects of cocaine in anesthetized and conscious rats. Life Sci. 40, 1099-1111.
31. Przywara, D.A., Dambach, G.E., 1989. Direct actions of cocaine on cardiac cellular electrical activity. Circ. Res. 65, 185-192.
32. Rankin, A.J., Wilson, N., Ledsome, J.R., 1987. Effects of autonomie stimulation on plasma immunoreactive atrial natriuretic peptide in the anesthetized rabbit. Can. J. Physiol. Pharmacol. 65, 532-537.
33. Rezkalla, S.H., Hale, S., Kloner, R.A., 1990. Cocaine-induced heart diseases. Am. Heart J. 120, 1403-1408.
34. Ritz, M.C., Lamb, R.J., Goldberg, S.R., Kuhar, M.J., 1987. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237, 1219-1223.
35. Ruskoaho, H., 1992. Atrial natriuretic peptide: synthesis, release, and metabolism. Pharmacol. Rev. 44, 479-602.
36. Ruskoaho, H., Taskinen, T., Pesonen, A., Vuolteenaho, O., Leppäluoto, J., Tuomisto, L., 1989a. Atrial natriuretic peptide in plasma, atria, ventricles and hypothalamus of Long-Evans and vasopressin-deficient Brattleboro rats. Endocrinology 124, 2595-2603.
37. Ruskoaho, H., Vakkuri, O., Arjamaa, O., Vuolteenaho, O., Leppäluoto, J., 1989b. Pressor hormones regulate atrial-stretch-induced release of atrial natriuretic peptide in the pithed rat. Circ. Res. 64, 482-492.
38. Schwartz, A.B., Boyle, W., Janzen, D., Jones, R.T., 1988. Acute effects of cocaine on catecholamines and cardiac electrophysiology in the conscious dog. Can. J. Cardiol. 4, 188-192.
39. Smith, T.L., Callahan, M., Williams, D., Dworkin, S.I., 1993. Tachyphylaxis in cardiovascular responses to cocaine in conscious rats. J. Cardiovasc. Pharmacol. 21, 272-278.
40. Stewart, J.M., Wang, J., Singer, A., et al., 1990. Regulation of plasma ANF after increases in afterload in conscious dogs. Am. J. Physiol. 259, H1736-H1742.
41. Sundsfjord, J.A., Thibault, G., Laracholle, P., Cantin, M., 1988. Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. J. Clin. Endocrinol. Metab. 66, 605-610.
42. Tella, S.R., Schindler, C.W., Goldberg, S.R., 1993. Cocaine: cardiovascular effects in relation to inhibition of peripheral neuronal monoamine uptake and central stimulation of the sympathoadrenal system. J. Pharmacol. Exp. Ther. 267, 153-162.
43. Vuolteenaho, O., Koistinen, P., Martikkala, V., Takala, T., Leppäluoto, J., 1992. Effect of physical exercise in hypobaric conditions on atrial natriuretic peptide secretion. Am. J. Physiol. 263, R647-R652.
44. Wang, T., Hadidi, F., Triana, F., Burgout, M., 1988. Morning report at Charity hospital: myocardial infarction associated with the use of cocaine. Am. J. Med. Sci. 295, 569-571.
45. Weiner, R.S., Lockhardt, J.T., Schwartz, R.G., 1986. Dilated cardiomyopathy and cocaine abuse: report of two cases. Am. J. Med. 81, 699-701.
46. Wilkerson, R.D., 1988. Cardiovascular effects of cocaine in conscious dogs: importance of fully functional autonomie and central nervous systems. J. Pharmacol. Exp. Ther. 246, 466-471.